Lucy Chesire, an HIV+ health care worker from Kenya who has had TB, talks about the importance of new tools in the fight against TB and shares how her personal experience persuades world leaders to listen. 

Jorge Bermudez, M.D., UNITAID executive secretary, explains how his organization's growing membership funds new second-line TB drug development and improved diagnostics for drug resistant TB. 

Mario Raviglione, M.D., director of the WHO's Stop TB Department, addresses the challenges with controlling drug resistant TB and the importance of political leadership in the fight against TB. 

Nils Billo, M.D., M.P.H., executive director of the The Union, discusses the conference theme of improving health systems globally and how TB programs in high-burden countries can help. 

Melvin Spigelman, M.D., incoming President and CEO of the Global Alliance for TB Drug Development, talks about drug resistant TB treatment now being tested and how it will be made available in low-income countries.